North Carolina Biotech CEOs – A Roundtable Interview With “The Pink Sheet” DAILY, Part 1
This article was originally published in The Pink Sheet Daily
Executive Summary
CEOs from five North Carolina-based biotechs discuss the challenges present in today’s FDA approval process.
You may also be interested in...
GSK/Pozen Win Long-awaited Approval For Combo Migraine Drug
Treximet will hit the U.S. market in mid-May, GSK says.
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately-owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.